This site displays a prototype of a “Web 2.0” version of the daily
Federal Register. It is not an official legal edition of the Federal
Register, and does not replace the official print version or the official
electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status.
For complete information about, and access to, our official publications
and services, go to
About the Federal Register
on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of
establishing the XML-based Federal Register as an ACFR-sanctioned
publication in the future. While every effort has been made to ensure that
the material on FederalRegister.gov is accurately displayed, consistent with
the official SGML-based PDF version on govinfo.gov, those relying on it for
legal research should verify their results against an official edition of
the Federal Register. Until the ACFR grants it official status, the XML
rendition of the daily Federal Register on FederalRegister.gov does not
provide legal notice to the public or judicial notice to the courts.
Notice
Enter a search term or FR citation e.g.
88 FR 38230 FR 78782024-13208USDA09/05/24RULE0503-AA39SORN
Choosing an item from
full text search results
will bring you to those results. Pressing enter in the search box
will also bring you to search results.
Choosing an item from
suggestions
will bring you directly to the content.
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before January 3, 2024. Such persons may also file a written request for a hearing on the application on or before January 3, 2024.
Table of Contents
Enhanced Content - Table of Contents
This table of contents is a navigational tool, processed from the
headings within the legal text of Federal Register documents.
This repetition of headings to form internal navigation links
has no substantive legal effect.
Comments are no longer being accepted.
See DATES for details.
Regulations.gov Data
Enhanced Content - Regulations.gov Data
FederalRegister.gov retrieves relevant information about this document
from Regulations.gov to provide users with additional context. This
information is not part of the official Federal Register document.
Importer of Controlled Substances Application Restek Corporation -DEA1305
Document page views are updated periodically throughout the day and are
cumulative counts for this document. Counts are subject to sampling,
reprocessing and revision (up or down) throughout the day.
Page views
88
as of
09/09/2026 at 6:15 am EDT
Other Formats
Enhanced Content - Other Formats
This document is also available in the following formats:
This PDF is FR Doc. 2023-26555 as it appeared on Public Inspection on
12/01/2023 at 8:45 am.
It was viewed
4
times while on Public Inspection.
If you are using public inspection listings for legal research, you
should verify the contents of the documents against a final, official
edition of the Federal Register. Only official editions of the
Federal Register provide legal notice of publication to the public and judicial notice
to the courts under 44 U.S.C. 1503 & 1507.
Learn more here.
Published Document: 2023-26555 (88 FR 84167)
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice of application.
SUMMARY:
Restek Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION
listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before January 3, 2024. Such persons may also file a written request for a hearing on the application on or before January 3, 2024.
ADDRESSES:
The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to
https://www.regulations.gov
and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on
https://www.regulations.gov.
If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.34(a), this is notice that on November 6, 2023, Restek Corporation, 110 Benner Circle, Bellefonte, Pennsylvania 16823-8433, applied to be registered as an importer of the following basic class(es) of controlled substance(s):
Controlled substance
Drug
code
Schedule
Amineptine
1219
I
Mesocarb
1227
I
3-Fluoro-N-methylcathinone (3-FMC)
1233
I
Cathinone
1235
I
Methcathinone
1237
I
4-Fluoro-N-methylcathinone (4-FMC)
1238
I
Para-Methoxymethamphetamine (PMMA), 1-(4-1245 I N methoxyphenyl)-N-methylpropan-2-amine
1245
I
Pentedrone (α-methylaminovalerophenone)
1246
I
Mephedrone (4-Methyl-N-methylcathinone)
1248
I
4-Methyl-N-ethylcathinone (4-MEC)
1249
I
Naphyrone
1258
I
N-Ethylamphetamine
1475
I
Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-1478 I N amine)
Dronabinol in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration (FDA)
7365
II
Nabilone
7379
II
1-Phenylcyclohexylamine
7460
II
Phencyclidine
7471
II
ANPP (4-Anilino-N-phenethyl-4-piperidine)
8333
II
Norfentanyl
8366
II
Phenylacetone
8501
II
1-Piperidinocyclohexanecarbonitrile
8603
II
Alphaprodine
9010
II
Anileridine
9020
II
Coca Leaves
9040
II
Cocaine
9041
II
Codeine
9050
II
Etorphine HCl
9059
II
Dihydrocodeine
9120
II
Oxycodone
9143
II
Hydromorphone
9150
II
Diphenoxylate
9170
II
Ecgonine
9180
II
Ethylmorphine
9190
II
Hydrocodone
9193
II
Levomethorphan
9210
II
Levorphanol
9220
II
Isomethadone
9226
II
Meperidine
9230
II
Meperidine-intermediate-A
9232
II
Meperidine intermediate-B
9233
II
Meperidine intermediate-C
9234
II
Metazocine
9240
II
Oliceridine
9245
II
Methadone
9250
II
Methadone intermediate
9254
II
Metopon
9260
II
Dextropropoxyphene, bulk (non-dosage forms)
9273
II
Morphine
9300
II
Oripavine
9330
II
Thebaine
9333
II
Dihydroetorphine
9334
II
Opium, raw
9600
II
Opium extracts
9610
II
Opium fluid extract
9620
II
Opium tincture
9630
II
Opium, powdered
9639
II
Opium, granulated
9640
II
Levo-alphacetylmethadol
9648
II
Opium poppy
9650
II
Oxymorphone
9652
II
Noroxymorphone
9668
II
Poppy Straw Concentrate
9670
II
Phenazocine
9715
II
Thiafentanil
9729
II
Piminodine
9730
II
Racemethorphan
9732
II
Racemorphan
9733
II
Alfentanil
9737
II
Remifentanil
9739
II
Sufentanil
9740
II
Carfentanil
9743
II
Tapentadol
9780
II
Bezitramide
9800
II
Fentanyl
9801
II
Moramide-intermediate
9802
II
The company plans to import the listed controlled substances for the use in the manufacture of exempted certified reference materials. No other activities for these drug codes are authorized for this registration.
Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale.